EID Parry Q1 FY27 Results (NSE: EIDPARRY)
Signal: Steady quarter
The read
The standalone business remains structurally weak: revenue fell 3.0% YoY to ₹73,312 lakh, pre-exceptional loss was ₹9,119 lakh and PAT loss widened to ₹8,929 lakh, while the consolidated group reported ₹14,160 lakh attributable PAT largely because subsidiaries contributed ₹38,190 lakh profit. The immediate inflection is the reduction in the PSRIPL-related exceptional charge to ₹1,868 lakh from ₹82,976 lakh in FY26, but the subsidiary still requires up to ₹13,000 lakh additional support and remains a material earnings-quality risk.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹9,017.52 Cr | N/A | N/A |
| EBIT | ₹537.59 Cr | N/A | |
| Net profit | ₹141.6 Cr | N/A |
P&L walk
Consolidated revenue from operations was ₹901,752 lakh and profit attributable to owners was ₹14,160 lakh; the result is dominated by subsidiaries, including ₹816,300 lakh revenue and ₹38,190 lakh net profit from eleven reviewed subsidiaries, but comparable consolidated P&L columns are not present in the supplied filing text.
Segments
Standalone distillery turned profitable at ₹866 lakh versus ₹2,027 lakh profit YoY and nutraceuticals improved to ₹1,377 lakh from a ₹20 lakh loss, but sugar remained loss-making at ₹4,867 lakh and consumer products lost ₹1,198 lakh; consolidated profit is instead lifted by subsidiaries contributing ₹38,190 lakh PAT.
Key positives
- Consolidated profit attributable to owners was ₹14,160 lakh, while eleven reviewed subsidiaries contributed ₹38,190 lakh net profit on ₹816,300 lakh revenue, demonstrating that group earnings are materially stronger than the standalone parent.
- Distillery segment result improved to ₹866 lakh from ₹2,027 lakh profit YoY despite revenue declining to ₹25,482 lakh from ₹29,584 lakh, indicating better segment profitability.
- Nutraceuticals moved from a ₹20 lakh loss to ₹1,377 lakh profit YoY, a ₹1,397 lakh turnaround.
- PSRIPL-related exceptional charge reduced to ₹1,868 lakh in Q1FY27 from ₹82,976 lakh recorded in FY26.
Key concerns
- Standalone revenue declined 3.0% YoY to ₹73,312 lakh while pre-exceptional loss widened to ₹9,119 lakh from ₹5,330 lakh, showing weak underlying parent operations.
- Sugar reported a ₹4,867 lakh loss and co-generation a ₹2,193 lakh loss; together they dragged segment results down despite distillery and nutraceutical improvements.
- Other income fell 57.5% YoY to ₹1,888 lakh, removing a prior support to the standalone bottom line.
- The company committed additional PSRIPL support of up to ₹13,000 lakh and disbursed ₹5,500 lakh during the quarter, creating continuing cash-allocation risk.
Research and educational content only. Not investment advice.